Naloxone can be repeated every two to three minutes if a person is still not breathing normally or not responding after the first dose. There is no hard ceiling on the number of doses you can give during an active overdose, because the immediate danger of not breathing outweighs the risks of additional naloxone. That said, the number of repeat doses that are appropriate, the timing between them, and what to watch for afterward depend on the opioid involved, the delivery method, and what else might be in the person’s system.
Why Naloxone Often Needs More Than One Dose
Naloxone works by pushing opioid molecules off the receptors in the brain that control breathing and consciousness.1PubMed Central. Clinical Pharmacokinetics and Pharmacodynamics of Naloxone It is fast and effective, but it has one major limitation: it wears off sooner than most opioids do. Naloxone’s effects typically last somewhere around 30 to 90 minutes, while many opioids remain active for hours. This duration mismatch means the opioid can outlast the naloxone, and the person can slip back into a life-threatening overdose state after an initial recovery. Doctors call this “re-narcotization.”2PubMed Central. Naloxone dosage for opioid reversal: current evidence and clinical implications
This is the core reason you may need to give more than one dose. The first dose might not fully reverse the overdose, especially if a large amount of opioid is on board. Or the first dose might work beautifully for twenty minutes and then the person starts going under again as the naloxone clears their system. Either scenario calls for another dose. The general guidance for bystanders and first responders is simple: if two to three minutes have passed and the person still is not responding, give another dose. If they responded and then start fading again, give another dose at that point too.
How Many Doses People Typically Need
Most opioid overdoses are reversed with one or two doses. Data from a large New York study comparing 4-milligram and 8-milligram intranasal naloxone found that people received an average of roughly 1.6 doses regardless of formulation strength, and survival rates exceeded 99 percent in both groups.3MMWR Morbidity and Mortality Weekly Report. Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose — New York, March 2022–August 2023 That average of about one and a half doses tells you that a good number of people are fine after just one spray, while a meaningful portion need a second, and a smaller share need more.
In a qualitative study of people who use opioids and have responded to overdoses in New York City, researchers catalogued 24 overdose events where repeat naloxone was given. About ten of those events involved a second dose within two minutes, seven involved a second dose between two and four minutes, and the remaining seven had a gap of more than four minutes. The reasons for quick re-dosing ranged from panic to a genuine recognition that the person was not responding.4PubMed Central. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City The study highlights a real tension in bystander situations: waiting two to three minutes when someone is turning blue feels like an eternity, and many people give a second dose faster than guidelines suggest.
In hospital settings, doctors sometimes give more than two or three doses, and in severe cases they may switch to a continuous intravenous drip rather than repeated individual doses. The drip approach maintains a steady level of naloxone in the blood and reduces the need for someone to keep watching the clock and re-dosing manually.
Does Fentanyl Require More Naloxone?
This is one of the most debated questions in emergency medicine right now, and the evidence points in two directions at once. On one hand, fentanyl is far more potent than heroin by weight, and it floods opioid receptors rapidly, which has led several researchers to argue that higher or more frequent doses of naloxone are needed to compete with all that fentanyl sitting on the receptors.5PubMed Central. Higher doses of naloxone are needed in the synthetic opiod era Clinicians in the field have reported individual cases where multiple doses seemed necessary to get a response.
On the other hand, a study that compared the naloxone doses actually required to treat overdose patients testing positive for fentanyl versus those testing positive for other opioids found no significant difference in how much naloxone was needed.6PubMed Central. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl The authors argued that fentanyl’s potency does not straightforwardly translate into needing more naloxone, partly because potency and receptor occupancy are not the same thing.
For a bystander, the practical takeaway is the same either way: give naloxone, wait two to three minutes, and give another dose if there is no response. Whether fentanyl theoretically requires more is a debate for toxicologists. What matters in the moment is that you keep dosing until the person breathes again or help arrives. If you happen to have two nasal sprays in your kit, you have enough for most overdoses. If your community distribution program offers kits with more doses, that extra margin is worth carrying.
How Delivery Method Affects Repeat Dosing
The route naloxone takes into the body changes how quickly it starts working, which in turn affects how long you might wait before deciding a repeat dose is needed. Intranasal spray (the kind you squirt up the nose) takes slightly longer to kick in compared with naloxone injected into a muscle or vein.7PubMed Central. Intranasal versus Intramuscular/Intravenous Naloxone for Pre-hospital Opioid Overdose: A Systematic Review and Meta-analysis That difference in onset is real but modest. Approved nasal sprays at 2-milligram and 4-milligram strengths produce naloxone blood levels that meet or exceed the older intramuscular benchmark, so the nasal route is not underpowered; it just needs a little more patience.8PubMed. Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review
When you are using intranasal naloxone, the two-to-three-minute wait before a repeat dose is especially important. Because the spray needs time to absorb through the nasal lining, giving a second spray after 30 seconds is unlikely to help much and will just double the total dose on board once it all absorbs. If the person vomits or has a lot of mucus in their nose, intranasal absorption can be impaired, and in those situations a second spray in the other nostril or switching to an intramuscular injection (if available) can help.
For injectable naloxone, the onset is faster, especially intravenously, and responders sometimes push small incremental doses of 0.04 to 0.4 milligrams every couple of minutes in a hospital setting. This incremental approach lets them titrate just enough naloxone to restore breathing without slamming the patient into full withdrawal. In a community setting, pre-loaded auto-injectors and nasal sprays do not allow that kind of fine-tuning, so the repeat-dosing strategy is necessarily coarser: full dose, wait, full dose again.
The Risks of Giving Too Much
Naloxone is remarkably safe in the sense that it has no abuse potential and does not suppress breathing on its own. But “safe to give” does not mean “no consequences.” Every dose of naloxone you stack on top of the last one increases the chances of precipitated withdrawal, which is what happens when the drug rips all the opioids off the receptors at once in someone who is physically dependent. A prehospital study found that patients who received multiple doses were about 20 percent more likely to meet criteria for precipitated withdrawal compared with those who received a single dose.9PubMed. Precipitated Withdrawal Induced by Prehospital Naloxone Administration Symptoms include a racing heart, vomiting, agitation, and severe discomfort. It is deeply unpleasant but not usually life-threatening.
The New York study comparing 4-milligram and 8-milligram nasal sprays saw a clear signal here: withdrawal symptoms including vomiting were about twice as common in the 8-milligram group compared with the 4-milligram group.3MMWR Morbidity and Mortality Weekly Report. Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose — New York, March 2022–August 2023 Agitation and combativeness were reported in roughly one in ten recipients regardless of dose. This matters because an agitated, vomiting person who has just been pulled out of an overdose can aspirate vomit, become violent toward the person helping them, or leave the scene against advice before the naloxone wears off.
Rarer but more serious complications include pulmonary edema, a condition where fluid floods the lungs. Case reports have linked this to rapid, high-dose naloxone reversal, likely because the sudden catecholamine surge from abrupt withdrawal can damage the lung’s capillaries.10PubMed Central. Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series Pulmonary edema is uncommon enough that it should never dissuade anyone from giving naloxone during an active overdose. But it is worth knowing that more naloxone is not always better. The goal is to restore breathing, not necessarily to make the person fully alert and conversational. In medical settings, clinicians aim for “just enough” to get the respiratory rate back up.
After the Last Dose Wears Off
Even if you successfully reverse an overdose with naloxone, the clock starts ticking again as soon as the naloxone begins to clear. Because the opioid may still be circulating or stored in the person’s tissues, there is a real window where they can slide back into an overdose with no new drug exposure at all. This is why calling emergency services is critical even when the person seems fine. The evidence on how long to watch someone after naloxone has centered on a one-hour observation period: if after one hour a person is walking normally, has stable vital signs, and is fully alert, the risk of deterioration is low.11PubMed. Do heroin overdose patients require observation after receiving naloxone? A clinical prediction rule known as the St. Paul’s Early Discharge Rule was developed around this same one-hour threshold.12PubMed. Hospital Observation Upon Reversal (HOUR) With Naloxone: A Prospective Clinical Prediction Rule Validation Study
One hour is a guideline for emergency departments, though. For bystanders who give naloxone outside a hospital, the takeaway is simpler: do not leave the person alone, and get them to professional medical care. If emergency services are delayed, staying with the person and being ready to give another dose is the safest approach. Long-acting opioids like methadone or extended-release oxycodone can require monitoring well beyond the one-hour mark, and a hospital may keep those patients for several hours or start a naloxone drip.
When the Overdose Involves More Than Opioids
Naloxone reverses opioid effects specifically. It does not work on benzodiazepines, alcohol, stimulants, or most other substances. In the current drug supply, many overdoses involve opioids mixed with other drugs, which complicates the picture. You might give naloxone and see partial improvement because the opioid component is reversed, but the person remains sedated or has abnormal breathing because of whatever else they took.
Xylazine, a veterinary tranquilizer that has become increasingly common in the street drug supply, is a particularly tricky addition. It is not an opioid and does not bind to opioid receptors, so naloxone should not, in theory, reverse its effects. Yet a case report documented a patient who received naloxone for a suspected xylazine overdose, showed immediate improvement in alertness, and then faded again within about 30 minutes, requiring re-dosing and eventually a continuous naloxone drip.13PubMed Central. The Management of Xylazine Overdose With Naloxone Because most xylazine exposures in the real world happen alongside fentanyl, the standard advice is to give naloxone anyway: you do not know what combination is on board, and reversing the opioid portion could be enough to restore breathing.
The practical lesson here is that repeated naloxone dosing might improve things partially but not completely when other depressants are involved. If the person is breathing on their own after naloxone but remains groggy or unresponsive, that persistent sedation is a sign something else is at work. Keep them in the recovery position (on their side), monitor their breathing, and wait for paramedics. Stacking more naloxone is unlikely to help once the opioid component has been addressed.
Naloxone Alone May Not Be Enough
One thing that gets lost in the focus on dosing is that naloxone is not the only intervention during an overdose. If a person is not breathing, rescue breathing provides oxygen while the naloxone works its way in. Research on take-home naloxone programs noted that naloxone alone may not always be sufficient to revive someone, and that cardiopulmonary resuscitation, especially rescue breathing, may also be needed.14PubMed. Take-home naloxone to reduce heroin death Giving a dose of naloxone and then watching the person lie motionless while waiting for it to kick in is not as effective as giving naloxone while also actively breathing for them. Each rescue breath delivers oxygen to the brain during the minutes when the naloxone is being absorbed.
This matters for the repeat-dosing question because if you are only relying on naloxone and nothing seems to work after two or three doses, the issue may not be that you need a fourth dose. It may be that the person needs ventilation support while the naloxone does its job. In community overdose response training, this combination of naloxone plus rescue breathing is emphasized far more than simply stacking doses.
Children and Pregnancy
Naloxone is used in children, though doses are weight-based and generally smaller. A study of intranasal naloxone in pediatric patients used a dose of 20 micrograms per kilogram up to a maximum of 0.4 milligrams, divided into repeated small doses across both nostrils, and found rapid systemic absorption.15PubMed. Rapid systemic uptake of naloxone after intranasal administration in children The same repeat-dosing logic applies to children: if the first dose does not restore adequate breathing within a few minutes, give another. For bystanders without access to weight-based dosing equipment, using a standard nasal spray on a child is still considered appropriate in a genuine emergency because the danger of untreated opioid overdose outweighs the risks of a relatively high dose for their size.
In pregnancy, naloxone use adds a layer of concern because precipitated withdrawal can trigger uterine contractions and fetal distress. Guidelines for managing opioid overdose in pregnant women emphasize that naloxone should still be given when the mother’s life is at risk but that the dose should be titrated carefully, using the smallest effective amount.16PubMed Central. Managing opioid overdose in pregnancy with take-home naloxone In practice, this means starting low and waiting a bit longer before re-dosing if possible, with the understanding that the mother needs to survive for the baby to survive. Pregnant individuals who receive naloxone should be transported to a hospital regardless of how well they appear to recover, because fetal monitoring is essential after any such event.
What Bystanders Should Actually Do
If you carry naloxone or encounter a situation where someone appears to be overdosing, the protocol most harm-reduction organizations teach can be distilled into a few steps. Call emergency services first. Give one dose of naloxone, either a nasal spray into one nostril or an intramuscular injection into the outer thigh. Start rescue breathing if the person is not breathing on their own. Wait two to three minutes. If they have not responded, give a second dose. Continue rescue breathing and monitoring until help arrives or the person is clearly recovering. If they improve and then start slipping back, give another dose at that point.
The two-to-three-minute window is a guideline, not a stopwatch rule. In the real world, panic, imperfect conditions, and uncertainty about what drugs are involved all play a role in how quickly people re-dose. The qualitative study of overdose responders in New York City makes this clear: many gave their second dose faster than guidelines recommend, sometimes within a minute.4PubMed Central. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City While waiting longer is preferable to reduce withdrawal risk, giving naloxone too fast is vastly preferable to not giving it at all. No one should hesitate to re-dose because they are worried about doing harm. The math is simple: an opioid overdose without intervention is often fatal, and precipitated withdrawal from too much naloxone, while miserable, almost never is.
Continuous Infusions in Hospital Settings
When paramedics or emergency doctors are managing a severe overdose, particularly one involving long-acting opioids like methadone or sustained-release formulations, they sometimes skip the repeated bolus approach entirely and place the patient on a continuous naloxone drip. The drip maintains a steady plasma concentration of naloxone so that as the drug is metabolized, more is delivered automatically. This approach is especially useful when the opioid on board has a duration of action measured in many hours or even days, as with methadone. It is also used when a patient keeps requiring re-dosing, signaling that discrete boluses are not maintaining adequate reversal between doses.
The xylazine case described earlier is an example of this escalation: after the patient’s consciousness dropped again following an initial bolus, the medical team started a naloxone drip at 2 milligrams per hour.13PubMed Central. The Management of Xylazine Overdose With Naloxone Continuous infusions are a hospital tool, not something available to bystanders, but they illustrate the principle that there is genuinely no upper limit on naloxone dosing when the clinical situation demands it. The constraint is not toxicity from naloxone itself but the side effects of overly aggressive reversal, primarily severe withdrawal and, rarely, pulmonary edema. In a monitored setting, those risks can be managed as they arise.